Should You Apply for an IPO Based on Its Grey Market Premium?

No, not based on GMP alone. In 2025, 56 of 101 mainboard IPOs listed below their grey market premium, meaning the informal indicator got it wrong more than half the time. GMP is useful as context. It's the last signal to check, not the first.

Key Takeaways

• 55% of 2025 mainboard IPOs listed below their grey market premium.
• GMP is unregulated, informal, and can move 30 to 40 points in the 48 hours before listing.
• GMP above 20% matters more when QIB oversubscription is also above 10x.
• Zepto's GMP of around 240 rupees reflects brand excitement, not a guaranteed listing day gain.
• Check fundamentals and QIB demand first. GMP is a final data point, not a deciding one.

Does Grey Market Premium Actually Predict IPO Listing Gains?

Not reliably. GMP correctly predicts the direction of a listing about 60 to 65% of the time on mainboard IPOs, based on 2025 data. The magnitude is far harder to call, and weak market conditions on listing day can override a strong GMP entirely.

With over 20 IPOs open in August 2026 and Zepto generating some of the loudest buzz this season, the temptation to use GMP as a shortcut is real. But a signal that fails more than half the time is not a shortcut. It is a coin flip with a label on it.

Grey market participants have no accountability. Their quotes respond to subscriptions, market mood, and rumor. Nothing stops a GMP from reaching 50% before the listing date and falling apart on the actual day.

What GMP Actually Measures (and What It Doesn't)

GMP is the price at which grey market dealers are willing to buy your allotted shares before the IPO lists on an exchange. It reflects informal pre-listing demand only, not the actual exchange price. The two can differ significantly, especially when market conditions shift between allotment and listing day.

The grey market is unregulated and operates with no SEBI oversight. Dealers quote prices based on subscription sentiment and the momentum of a hot name, mostly. Sentiment can spread accross forums and social media quickly, driving a GMP up or down overnight without any change in the company's actual business.

A few things GMP doesn't account for: market falls between allotment and listing, institutional selling pressure on day one, and the exit of grey market dealers from their own positions before listing. That last point is why you can see a GMP of 80 rupees on Thursday and a disappointing listing on Monday.

GMP tends to be most accurate when an IPO is heavily oversubscribed across all investor categories, particularly where qualified institutional buyers have bid aggressively. Their participation is a stronger signal than GMP alone. Treat them as seperate inputs, not one combined signal when you're deciding whether to apply.

GMP vs. QIB Subscription vs. Fundamentals

When Should You Pay Attention to GMP?

When GMP rises above 20% alongside QIB oversubscription above 10x, that combination has correlated with positive listings in roughly 70 to 75% of mainboard IPOs. GMP standing alone is a weaker signal. It needs institutional conviction behind it to mean much.

A few situations where GMP earns a closer look:

• GMP rising in the final 48 hours before listing. Often signals that HNI and institutional investors are buying grey market shares to speculate on listing gains. Strong short-term conviction, though it can be self-fulfilling before it unwinds.
• Negative or collapsing GMP. A meaningful warning, even for IPOs with strong subscription numbers. Watch the direction, not just the level.
• GMP above 20% with QIB oversubscription above 10x. The combination that actually carries some predictive weight. Neither alone is enough.

Take Zepto, the most talked-about IPO of August 2026. Issue size of 8,010 crore rupees. A GMP of around 240 rupees heading into its listing window. That is an exciting number. But Zepto is not profitable yet, and quick commerce valuations have been volatile all year. The GMP is tracking brand enthusiasm. Whether the exchange recieve that enthusiasm the same way on listing day is a completely separate question.

Should You Actually Use GMP to Decide?

Use it as one input among five. GMP is worth considering when it aligns with strong QIB demand, solid total subscription, fair valuation, and a stable market. When it's the only positive indicator, that should give you pause rather than confidence.

A practical filter before you submit an application:

1. Are the company's fundamentals decent for the price band on offer?
2. Is QIB oversubscription above 10x?
3. Is total subscription above 20x?
4. Is GMP positive and holding steady in the 48 hours before listing?
5. Is the broader market reasonably stable this week?

Four or five yeses puts the odds more in your favour. If GMP is the only yes, slow down rather than rush in.

And keep this in mind: most retail investors in India apply for allotment through a lottery. If you don't get allotted, GMP never mattered anyway. Keep the time spent tracking it proportionate to your actual odds of receiving shares.

Frequently Asked Questions

What does a high IPO GMP mean?

A high grey market premium suggests strong pre-listing demand in the informal market, typically meaning investors expect the stock to list above its issue price. But GMP is unregulated and informal. In 2025, 55% of mainboard IPOs listed below their GMP despite positive pre-listing sentiment. High GMP does not mean guaranteed gains.

Is IPO GMP regulated by SEBI?

No. GMP operates entirely outside SEBI's oversight. It is quoted by informal grey market dealers with no regulatory framework, no central record, and no accountability if the number turns out wrong. Treating it as official market data is one of the most common mistakes among first-time IPO investors in India.

What is a good GMP percentage before listing?

A GMP above 15 to 20% is considered positive informal sentiment. The number means more when it comes alongside QIB oversubscription above 10x and total subscription above 20x. Without those, even a 40% GMP has produced flat or negative listings on mainboard IPOs in India.

Can GMP go negative before an IPO lists?

Yes. A negative GMP means grey market dealers expect the stock to list below the issue price. This is a meaningful warning and has appeared before several underperforming listings, including SME IPOs where retail demand during subscriptions outpaced what the underlying business fundamentals actually supported.

How accurate is IPO GMP in predicting listing gains?

GMP correctly predicts the direction of the listing about 60 to 65% of the time on mainboard IPOs, based on 2025 data. Predicting the magnitude is much harder. SME IPO GMP tends to be less reliable than mainboard GMP, and accuracy drops in volatile broader market conditions.

The Short Version

GMP tracks informal demand, and it's often wrong. More than half of 2025's mainboard IPOs listed below their grey market premium. The number worth watching alongside GMP is QIB oversubscription. When both are strong, the odds improve. When only GMP is high, treat that excitement with real skepticism before applying.

This is general information, not investment advice. IPO investing carries risk. Read the Red Herring Prospectus before applying to any offering.